Insights into Multiple Myeloma: Immune Microenvironment, Disease Mechanisms, and Therapeutic Innovations

Dear Colleagues,

Multiple myeloma (MM) remains an incurable hematologic malignancy despite significant advances in treatment in recent years. A deeper understanding of the disease biology—including the bone marrow microenvironment, mechanisms of disease progression, and treatment resistance—is essential for the development of future therapies. This Special Issue invites a broad range of contributions that reflect the diverse and evolving landscape of MM research. We welcome studies across all stages of research, including basic, translational, and clinical investigations in areas such as molecular biology, immunology, novel therapeutic strategies, clinical trials, and real-world data. In particular, we strongly encourage submissions focusing on immunology and immunotherapeutic approaches, including monoclonal antibodies, CAR-T cells, bispecific antibodies, and antibody-drug conjugates, which are playing an increasingly central role in MM treatment. Submissions may include original research articles, comprehensive reviews, and expert perspectives. Through this Special Issue, we aim to foster a deeper understanding of MM and contribute to future advances in treatment and patient care by assembling an inclusive body of knowledge.

Dr. Ichiro Hanamura
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.